Analyst Consensus ?
ConsensusBuy44 ratings
Bullish2863.6%
Neutral1636.4%
Bearish00.0%
FN2 Earnings Intelligence
Johnson Controls International plc (JCI) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Mizuho | Neutral | Neutral | Maintain | Oct 15, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Oct 14, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Oct 12, 2026 |
| B of A Securities | Buy | Buy | Maintain | Oct 8, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Sep 2, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Aug 14, 2026 |
| UBS | Buy | Buy | Maintain | Jun 2, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | May 7, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | May 7, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Feb 6, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Nov 7, 2025 |
| Argus Research | Buy | Buy | Maintain | Nov 7, 2025 |
| Jefferies | Hold | Buy | Downgrade | Jul 24, 2025 |
| Baird | Neutral | Neutral | Maintain | Jul 17, 2025 |
| Oppenheimer | Perform | Outperform | Downgrade | Jun 20, 2025 |
| Deutsche Bank | Buy | Hold | Upgrade | May 12, 2025 |
| Melius Research | Hold | Buy | Downgrade | Jan 28, 2025 |
| HSBC | Hold | Buy | Downgrade | Jan 31, 2024 |
| Vertical Research | Hold | Buy | Downgrade | Dec 13, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Nov 4, 2022 |
| OTR Global | Positive | Mixed | Upgrade | Apr 27, 2021 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Dec 9, 2020 |
| CFRA | Buy | Buy | Maintain | May 1, 2020 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Jan 9, 2020 |
| Cowen & Co. | Market Perform | Market Perform | Maintain | Feb 19, 2019 |
| Argus | Buy | Hold | Upgrade | Aug 21, 2018 |
| Susquehanna | Neutral | Positive | Downgrade | Nov 15, 2017 |
| Vertical Group | Hold | Buy | Downgrade | Nov 10, 2017 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Oct 23, 2017 |
| Macquarie | Outperform | Outperform | Maintain | Sep 8, 2016 |
| William Blair | Market Perform | Outperform | Downgrade | Dec 2, 2015 |
| Nomura | Buy | Buy | Maintain | Oct 2, 2015 |
| Ascendiant Capital | Buy | Buy | Maintain | Dec 23, 2014 |
| FBR Capital | Outperform | Outperform | Maintain | Feb 19, 2014 |
| Lazard | Buy | Neutral | Upgrade | May 13, 2013 |
| Credit Agricole | Buy | Outperform | Maintain | Mar 14, 2013 |
| Stifel Nicolaus | Buy | Buy | Maintain | Nov 1, 2012 |
| Stifel | Buy | Buy | Maintain | Nov 1, 2012 |
| Needham | Hold | Buy | Downgrade | Nov 1, 2012 |
| Sterne Agee | Neutral | Neutral | Maintain | Jul 24, 2012 |
| Bank of America | Buy | Buy | Maintain | Jul 19, 2012 |
| Wunderlich Securities | Buy | Buy | Maintain | Jul 6, 2012 |
| Wunderlich | Buy | Buy | Maintain | Jul 6, 2012 |
| Guggenheim | Buy | Buy | Maintain | Mar 7, 2012 |
Upside is calculated against the persisted current price $154.48. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Mizuho Securities | Analyst unavailable | $165 | $152.44 | +6.8% | Oct 15, 2026 |
| Wells Fargo | Analyst unavailable | $186 | $145.36 | +20.4% | Sep 24, 2026 |
| Morgan Stanley | Analyst unavailable | $180 | $138.46 | +16.5% | Sep 2, 2026 |
| Bernstein | Analyst unavailable | $190 | $152.36 | +23.0% | Aug 14, 2026 |
| Argus Research | John Eade | $175 | $154.55 | +13.3% | Aug 7, 2026 |
| Bernstein | Analyst unavailable | $176 | $147.75 | +13.9% | Jun 9, 2026 |
| Morgan Stanley | Chris Snyder | $175 | $144.05 | +13.3% | Jun 9, 2026 |
| Wolfe Research | Analyst unavailable | $171 | $141.99 | +10.7% | Jun 3, 2026 |
| UBS | Amit Mehrotra | $180 | $141.26 | +16.5% | Jun 2, 2026 |
| RBC Capital | Analyst unavailable | $154 | $139.12 | -0.3% | May 7, 2026 |
| Barclays | Julian Mitchell | $144 | $143.14 | -6.8% | May 7, 2026 |
| Morgan Stanley | Christopher Snyder | $140 | $134.99 | -9.4% | Mar 11, 2026 |
| RBC Capital | Deane Dray | $140 | $131.97 | -9.4% | Feb 5, 2026 |
| Mizuho Securities | Analyst unavailable | $130 | $131.39 | -15.8% | Feb 5, 2026 |
| Goldman Sachs | Analyst unavailable | $154 | $129.49 | -0.3% | Feb 5, 2026 |
| Robert W. Baird | Analyst unavailable | $132 | $129.49 | -14.6% | Feb 5, 2026 |
| Barclays | Analyst unavailable | $136 | $129.49 | -12.0% | Feb 5, 2026 |
| Morgan Stanley | Analyst unavailable | $130 | $111.51 | -15.8% | Jan 13, 2026 |
| Melius Research | Scott Davis | $148 | $113.95 | -4.2% | Jan 7, 2026 |
| Barclays | Analyst unavailable | $125 | $113.95 | -19.1% | Jan 7, 2026 |
| Goldman Sachs | Analyst unavailable | $142 | $122.25 | -8.1% | Nov 6, 2025 |
| UBS | Amit Mehrotra | $124 | $123 | -19.7% | Nov 6, 2025 |
| Barclays | Julian Mitchell | $90 | $95.28 | -41.7% | May 14, 2025 |
| Wells Fargo | Joe O’Dea | $100 | $91.68 | -35.3% | May 8, 2025 |
| Barclays | Analyst unavailable | $85 | $80.07 | -45.0% | Mar 10, 2025 |
| Wells Fargo | Joesph O'Dea | $92 | $79.17 | -40.4% | Jan 7, 2025 |
| Argus Research | John Eade | $88 | $79.25 | -43.0% | Dec 20, 2024 |
| Bank of America Securities | Andrew Obin | $80 | $68.6 | -48.2% | Sep 10, 2024 |
| Morgan Stanley | Chris Snyder | $85 | $69.38 | -45.0% | Sep 6, 2024 |
| RBC Capital | Sector Perform | $69 | $67.82 | -55.3% | Aug 14, 2024 |
| RBC Capital | Deane Dray | $61 | $71.03 | -60.5% | Aug 1, 2024 |
| Barclays | Julian Mitchell | $62 | $68.19 | -59.9% | Jun 21, 2024 |
| Barclays | Julian Mitchell | $61 | $65.13 | -60.5% | Apr 2, 2024 |
| Citigroup | Andrew Kaplowitz | $58 | $56.08 | -62.5% | Dec 11, 2023 |
| Morgan Stanley | Joshua Pokrzywinski | $73 | $58.51 | -52.7% | May 5, 2023 |
| Oppenheimer | Analyst unavailable | $72 | $66.36 | -53.4% | Feb 2, 2023 |
| Wells Fargo | Analyst unavailable | $72 | $65.02 | -53.4% | Jan 5, 2023 |
| Barclays | Analyst unavailable | $75 | $65.65 | -51.5% | Jan 5, 2023 |
| Citigroup | Analyst unavailable | $68 | $65.77 | -56.0% | Dec 9, 2022 |
| Deutsche Bank | Analyst unavailable | $74 | $66.98 | -52.1% | Dec 5, 2022 |
| J.P. Morgan | Analyst unavailable | $70 | $67.63 | -54.7% | Dec 2, 2022 |
| Morgan Stanley | Analyst unavailable | $62 | $54.89 | -59.9% | Sep 1, 2022 |
| Morgan Stanley | Analyst unavailable | $61 | $55.53 | -60.5% | Aug 8, 2022 |
| Oppenheimer | Analyst unavailable | $63 | $55.1 | -59.2% | Aug 8, 2022 |
| Jefferies | Stephen Volkmann | $65 | $50.34 | -57.9% | Jul 26, 2022 |
| Mizuho Securities | Analyst unavailable | $65 | $47.03 | -57.9% | Jul 18, 2022 |
| Barclays | Analyst unavailable | $60 | $47.67 | -61.2% | Jul 8, 2022 |
| Morgan Stanley | Analyst unavailable | $54 | $47.82 | -65.0% | Jul 7, 2022 |
| Wells Fargo | Analyst unavailable | $60 | $48.44 | -61.2% | Jun 29, 2022 |
| Goldman Sachs | Analyst unavailable | $62 | $47.44 | -59.9% | Jun 23, 2022 |
| Morgan Stanley | Joshua Pokrzywinski | $59 | $55 | -61.8% | Jun 7, 2022 |
| Barclays | Analyst unavailable | $65 | $50.89 | -57.9% | May 24, 2022 |
| RBC Capital | Analyst unavailable | $61 | $54.59 | -60.5% | May 5, 2022 |
| Credit Suisse | John Walsh | $73 | $54.83 | -52.7% | May 5, 2022 |
| Morgan Stanley | Analyst unavailable | $71 | $54.84 | -54.0% | May 5, 2022 |
| Barclays | Julian Mitchell | $80 | $66.2 | -48.2% | Apr 5, 2022 |
| Mizuho Securities | Brett Linzey | $88 | $68.88 | -43.0% | Feb 3, 2022 |
| Jefferies | Stephen Volkmann | $90 | $73.39 | -41.7% | Jan 24, 2022 |
| Cowen & Co. | Gautam Khanna | $86 | $80.87 | -44.3% | Dec 31, 2021 |
| UBS | Markus Mittermaier | $92 | $77.03 | -40.4% | Dec 14, 2021 |
| Citigroup | Andrew Kaplowitz | $81 | $73.75 | -47.6% | Nov 8, 2021 |
| Oppenheimer | Noah Kaye | $86 | $74.62 | -44.3% | Sep 9, 2021 |
| HSBC | Puneet Garg | $66 | $70.41 | -57.3% | Aug 4, 2021 |
| Wolfe Research | Nigel Coe | $83 | $69.75 | -46.3% | Jul 12, 2021 |
| Goldman Sachs | Joe Ritchie | $83 | $67.72 | -46.3% | Jun 30, 2021 |
| Argus Research | John Eade | $72 | $63.75 | -53.4% | May 6, 2021 |
Track every rating change on JCI the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.